Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.039203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Ishmam Ibtida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiology Service Memorial Sloan Kettering Cancer Center New York New York USA. Hauptthemen laut MEDLINE: Electrocardiography, Breast Neoplasms, Anthracyclines, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background Strategies to estimate risk of cancer therapy‐related cardiac dysfunction (CTRCD) before initiating cardiotoxic cancer treatment are needed. We hypothesized that baseline ECG markers could identify patients at risk for CTRCD. Methods and Results In this retrospective cohort study, 1278 female patients with stage I–III HER2 (human epidermal growth factor receptor 2)‐positive breast cancer meeting the following inclusion criteria were included: baseline ECG with QRS
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Cardiology Service Memorial Sloan Kettering Cancer Center New York New York USA.
- Division of Biostatistics and Epidemiology, Department of Health Care Policy and Research Weill Cornell Medicine New York New York USA.
- Department of Medicine Weill Cornell Medical College New York New York USA.
- Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA.
- Greenberg Division of Cardiology, Department of Medicine Weill Cornell Medicine New York New York USA.
ORCID-Profile: Mohammed Al-Sadawi, Ioanna Kosmidou, Anthony F Yu
Förderung
- NCI NIH HHS
Zitieren
APA
Ibtida, I., Ma, X., Al-Sadawi, M., Kosmidou, I., Herrmann, J., Liu, J. E., Okin, P. M., & Yu, A. F. (2025). Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039203
Vancouver
Ibtida I, Ma X, Al-Sadawi M, Kosmidou I, Herrmann J, Liu JE, et al. Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039203
BibTeX
@article{Ibtida2025,
author = {Ibtida, Ishmam and Ma, Xiaoyue and Al-Sadawi, Mohammed and Kosmidou, Ioanna and Herrmann, Joerg and Liu, Jennifer E and Okin, Peter M and Yu, Anthony F},
title = {Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.039203}
}
EUVIMED